Optiscan Imaging Ltd (ASX:OIL) Share Price

Company Profile

Business description
Optiscan Imaging Ltd is engaged in the development, manufacture and commercialisation of proprietary confocal imaging devices and digital solutions for surgical, pathology and veterinary applications. Activities included the advancement of the company's InVueTM, InFormTM and InSpectaTM platforms through product development, clinical studies, regulatory activities, strategic collaborations and commercialisation initiatives. The group operated predominantly in the confocal microscope industry. It has presence in Germany, China, Australia, and United States. Majority of revenue comes from Germany. Its products are Optiscan InVueTM, Optiscan InFormTM, Optiscan InVivage, Optiscan ViewnVivo, and Optiscan InSpectaTM.
Contact
16 Miles Street
Mulgrave
MelbourneVIC3170
AUS
T: +61 395983333
https://www.optiscan.com
Sector
Technology
Stock type
Sensitive
Industry
Scientific & Technical Instruments
Fiscal Year End
Employees
33

Recommended

We see regulatory risk from both the US and Chinese governments.

Seth Goldstein, CFA | 25 October 2026

Near-term pain, long-term potential.

Dan Baker | 22 October 2026

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.

Malik Ahmed Khan, CFA | 22 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,921.00	15.20	0.17%
CAC 40	7,782.82	28.44	-0.36%
DAX 40	25,181.65	190.10	-0.75%
Dow JONES (US)	52,215.16	652.82	-1.23%
FTSE 100	10,690.36	34.67	-0.32%
HKSE	23,193.94	100.57	0.44%
NASDAQ	25,955.34	53.52	-0.21%
Nikkei 225	62,503.82	189.34	-0.30%
NZX 50 Index	13,733.93	12.91	-0.09%
S&P 500	7,623.68	39.75	-0.52%
S&P/ASX 200	8,805.60	10.40	0.12%
SSE Composite Index	3,683.92	6.56	-0.18%